Orlistat Overcoming Third-generation EGFR-TKI Resistance

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Orlistat Overcoming Third-generation EGFR-TKI Resistance	Neoplasms by Histologic Type, Neoplasms by Site, Thoracic Neoplasms, adenocarcinoma, carcinoma, epithelial neoplasm, lung adenocarcinoma, lung neoplasm, neoplasm, respiratory tract neoplasm	Not yet recruiting	Phase 2	2025-02-12		NCT06818955

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Hubei Cancer Hospital	29
Ping Peng	1

0 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
No products are listed yet.

Clinical trials